ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Acute Respiratory Distress Syndrome Therapeutics Market Research Report 2024
Published Date: August 2024
|
Report Code: QYRE-Auto-5W13922
Home | Market Reports | Health| Health Conditions
Global Acute Respiratory Distress Syndrome Therapeutics Market Research Report 2023
BUY CHAPTERS

Global Acute Respiratory Distress Syndrome Therapeutics Market Research Report 2024

Code: QYRE-Auto-5W13922
Report
August 2024
Pages:87
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Therabron Therapeutics Inc
Serendex Pharmaceuticals A/S
Silence Therapeutics Plc
Histocell S.L.
Altor BioScience Corporation
Athersys
Faron Pharmaceuticals Oy
FirstString Research Inc
GlaxoSmithKline PLC
Phylogica Ltd

Acute Respiratory Distress Syndrome Therapeutics Market Size

The global Acute Respiratory Distress Syndrome Therapeutics market was valued at US$ 377.7 million in 2023 and is anticipated to reach US$ 469.8 million by 2030, witnessing a CAGR of 3.1% during the forecast period 2024-2030.

Acute Respiratory Distress Syndrome Therapeutics Market

Acute Respiratory Distress Syndrome Therapeutics Market

Respiratory distress syndrome is caused by pulmonary surfactant deficiency in the lungs of neonates, most commonly in those born at < 37 weeks’ gestation. Risk increases with degree of prematurity. Symptoms and signs include grunting respirations, use of accessory muscles, and nasal flaring appearing soon after birth. Diagnosis is clinical; prenatal risk can be assessed with tests of fetal lung maturity. Treatment is surfactant therapy and supportive care. Treatment for RDS usually begins as soon as a newborn is born, sometimes in the delivery room. Treatments for RDS include surfactant replacement therapy, breathing support from a ventilator or nasal continuous positive airway pressure (NCPAP) machine, or other supportive treatments.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Acute Respiratory Distress Syndrome Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Acute Respiratory Distress Syndrome Therapeutics.

Report Scope

The Acute Respiratory Distress Syndrome Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Acute Respiratory Distress Syndrome Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Acute Respiratory Distress Syndrome Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Acute Respiratory Distress Syndrome Therapeutics Market Report

Report Metric Details
Report Name Acute Respiratory Distress Syndrome Therapeutics Market
Accounted market size in 2023 US$ 377.7 million
Forecasted market size in 2030 US$ 469.8 million
CAGR 3.1%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
Segment by Application
  • In-Patient
  • Out-Patient
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Therabron Therapeutics, Inc., Serendex Pharmaceuticals A/S, Silence Therapeutics Plc, Histocell S.L., Altor BioScience Corporation, Athersys, Inc., Faron Pharmaceuticals Oy, FirstString Research, Inc., GlaxoSmithKline Plc, Phylogica Limited
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Acute Respiratory Distress Syndrome Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Acute Respiratory Distress Syndrome Therapeutics Market growing?

Ans: The Acute Respiratory Distress Syndrome Therapeutics Market witnessing a CAGR of 3.1% during the forecast period 2024-2030.

What is the Acute Respiratory Distress Syndrome Therapeutics Market size in 2030?

Ans: The Acute Respiratory Distress Syndrome Therapeutics Market size in 2030 will be US$ 469.8 million.

Who are the main players in the Acute Respiratory Distress Syndrome Therapeutics Market report?

Ans: The main players in the Acute Respiratory Distress Syndrome Therapeutics Market are Therabron Therapeutics, Inc., Serendex Pharmaceuticals A/S, Silence Therapeutics Plc, Histocell S.L., Altor BioScience Corporation, Athersys, Inc., Faron Pharmaceuticals Oy, FirstString Research, Inc., GlaxoSmithKline Plc, Phylogica Limited

What are the Application segmentation covered in the Acute Respiratory Distress Syndrome Therapeutics Market report?

Ans: The Applications covered in the Acute Respiratory Distress Syndrome Therapeutics Market report are In-Patient, Out-Patient

What are the Type segmentation covered in the Acute Respiratory Distress Syndrome Therapeutics Market report?

Ans: The Types covered in the Acute Respiratory Distress Syndrome Therapeutics Market report are Methylprednisolone, Hydrocortisone, Calf Pulmonary Surfactant for Injection, Others

Recommended Reports

Respiratory Devices

Respiratory Therapeutics

Respiratory Diagnostics

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Acute Respiratory Distress Syndrome Therapeutics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Methylprednisolone
1.2.3 Hydrocortisone
1.2.4 Calf Pulmonary Surfactant for Injection
1.2.5 Others
1.3 Market by Application
1.3.1 Global Acute Respiratory Distress Syndrome Therapeutics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 In-Patient
1.3.3 Out-Patient
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Acute Respiratory Distress Syndrome Therapeutics Market Perspective (2019-2030)
2.2 Acute Respiratory Distress Syndrome Therapeutics Growth Trends by Region
2.2.1 Global Acute Respiratory Distress Syndrome Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Acute Respiratory Distress Syndrome Therapeutics Historic Market Size by Region (2019-2024)
2.2.3 Acute Respiratory Distress Syndrome Therapeutics Forecasted Market Size by Region (2025-2030)
2.3 Acute Respiratory Distress Syndrome Therapeutics Market Dynamics
2.3.1 Acute Respiratory Distress Syndrome Therapeutics Industry Trends
2.3.2 Acute Respiratory Distress Syndrome Therapeutics Market Drivers
2.3.3 Acute Respiratory Distress Syndrome Therapeutics Market Challenges
2.3.4 Acute Respiratory Distress Syndrome Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Acute Respiratory Distress Syndrome Therapeutics Players by Revenue
3.1.1 Global Top Acute Respiratory Distress Syndrome Therapeutics Players by Revenue (2019-2024)
3.1.2 Global Acute Respiratory Distress Syndrome Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Acute Respiratory Distress Syndrome Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Acute Respiratory Distress Syndrome Therapeutics Revenue
3.4 Global Acute Respiratory Distress Syndrome Therapeutics Market Concentration Ratio
3.4.1 Global Acute Respiratory Distress Syndrome Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Acute Respiratory Distress Syndrome Therapeutics Revenue in 2023
3.5 Acute Respiratory Distress Syndrome Therapeutics Key Players Head office and Area Served
3.6 Key Players Acute Respiratory Distress Syndrome Therapeutics Product Solution and Service
3.7 Date of Enter into Acute Respiratory Distress Syndrome Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Acute Respiratory Distress Syndrome Therapeutics Breakdown Data by Type
4.1 Global Acute Respiratory Distress Syndrome Therapeutics Historic Market Size by Type (2019-2024)
4.2 Global Acute Respiratory Distress Syndrome Therapeutics Forecasted Market Size by Type (2025-2030)
5 Acute Respiratory Distress Syndrome Therapeutics Breakdown Data by Application
5.1 Global Acute Respiratory Distress Syndrome Therapeutics Historic Market Size by Application (2019-2024)
5.2 Global Acute Respiratory Distress Syndrome Therapeutics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Acute Respiratory Distress Syndrome Therapeutics Market Size (2019-2030)
6.2 North America Acute Respiratory Distress Syndrome Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Acute Respiratory Distress Syndrome Therapeutics Market Size by Country (2019-2024)
6.4 North America Acute Respiratory Distress Syndrome Therapeutics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Acute Respiratory Distress Syndrome Therapeutics Market Size (2019-2030)
7.2 Europe Acute Respiratory Distress Syndrome Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Acute Respiratory Distress Syndrome Therapeutics Market Size by Country (2019-2024)
7.4 Europe Acute Respiratory Distress Syndrome Therapeutics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Acute Respiratory Distress Syndrome Therapeutics Market Size (2019-2030)
8.2 Asia-Pacific Acute Respiratory Distress Syndrome Therapeutics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Acute Respiratory Distress Syndrome Therapeutics Market Size by Region (2019-2024)
8.4 Asia-Pacific Acute Respiratory Distress Syndrome Therapeutics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Acute Respiratory Distress Syndrome Therapeutics Market Size (2019-2030)
9.2 Latin America Acute Respiratory Distress Syndrome Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Acute Respiratory Distress Syndrome Therapeutics Market Size by Country (2019-2024)
9.4 Latin America Acute Respiratory Distress Syndrome Therapeutics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Acute Respiratory Distress Syndrome Therapeutics Market Size (2019-2030)
10.2 Middle East & Africa Acute Respiratory Distress Syndrome Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Acute Respiratory Distress Syndrome Therapeutics Market Size by Country (2019-2024)
10.4 Middle East & Africa Acute Respiratory Distress Syndrome Therapeutics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Therabron Therapeutics, Inc.
11.1.1 Therabron Therapeutics, Inc. Company Detail
11.1.2 Therabron Therapeutics, Inc. Business Overview
11.1.3 Therabron Therapeutics, Inc. Acute Respiratory Distress Syndrome Therapeutics Introduction
11.1.4 Therabron Therapeutics, Inc. Revenue in Acute Respiratory Distress Syndrome Therapeutics Business (2019-2024)
11.1.5 Therabron Therapeutics, Inc. Recent Development
11.2 Serendex Pharmaceuticals A/S
11.2.1 Serendex Pharmaceuticals A/S Company Detail
11.2.2 Serendex Pharmaceuticals A/S Business Overview
11.2.3 Serendex Pharmaceuticals A/S Acute Respiratory Distress Syndrome Therapeutics Introduction
11.2.4 Serendex Pharmaceuticals A/S Revenue in Acute Respiratory Distress Syndrome Therapeutics Business (2019-2024)
11.2.5 Serendex Pharmaceuticals A/S Recent Development
11.3 Silence Therapeutics Plc
11.3.1 Silence Therapeutics Plc Company Detail
11.3.2 Silence Therapeutics Plc Business Overview
11.3.3 Silence Therapeutics Plc Acute Respiratory Distress Syndrome Therapeutics Introduction
11.3.4 Silence Therapeutics Plc Revenue in Acute Respiratory Distress Syndrome Therapeutics Business (2019-2024)
11.3.5 Silence Therapeutics Plc Recent Development
11.4 Histocell S.L.
11.4.1 Histocell S.L. Company Detail
11.4.2 Histocell S.L. Business Overview
11.4.3 Histocell S.L. Acute Respiratory Distress Syndrome Therapeutics Introduction
11.4.4 Histocell S.L. Revenue in Acute Respiratory Distress Syndrome Therapeutics Business (2019-2024)
11.4.5 Histocell S.L. Recent Development
11.5 Altor BioScience Corporation
11.5.1 Altor BioScience Corporation Company Detail
11.5.2 Altor BioScience Corporation Business Overview
11.5.3 Altor BioScience Corporation Acute Respiratory Distress Syndrome Therapeutics Introduction
11.5.4 Altor BioScience Corporation Revenue in Acute Respiratory Distress Syndrome Therapeutics Business (2019-2024)
11.5.5 Altor BioScience Corporation Recent Development
11.6 Athersys, Inc.
11.6.1 Athersys, Inc. Company Detail
11.6.2 Athersys, Inc. Business Overview
11.6.3 Athersys, Inc. Acute Respiratory Distress Syndrome Therapeutics Introduction
11.6.4 Athersys, Inc. Revenue in Acute Respiratory Distress Syndrome Therapeutics Business (2019-2024)
11.6.5 Athersys, Inc. Recent Development
11.7 Faron Pharmaceuticals Oy
11.7.1 Faron Pharmaceuticals Oy Company Detail
11.7.2 Faron Pharmaceuticals Oy Business Overview
11.7.3 Faron Pharmaceuticals Oy Acute Respiratory Distress Syndrome Therapeutics Introduction
11.7.4 Faron Pharmaceuticals Oy Revenue in Acute Respiratory Distress Syndrome Therapeutics Business (2019-2024)
11.7.5 Faron Pharmaceuticals Oy Recent Development
11.8 FirstString Research, Inc.
11.8.1 FirstString Research, Inc. Company Detail
11.8.2 FirstString Research, Inc. Business Overview
11.8.3 FirstString Research, Inc. Acute Respiratory Distress Syndrome Therapeutics Introduction
11.8.4 FirstString Research, Inc. Revenue in Acute Respiratory Distress Syndrome Therapeutics Business (2019-2024)
11.8.5 FirstString Research, Inc. Recent Development
11.9 GlaxoSmithKline Plc
11.9.1 GlaxoSmithKline Plc Company Detail
11.9.2 GlaxoSmithKline Plc Business Overview
11.9.3 GlaxoSmithKline Plc Acute Respiratory Distress Syndrome Therapeutics Introduction
11.9.4 GlaxoSmithKline Plc Revenue in Acute Respiratory Distress Syndrome Therapeutics Business (2019-2024)
11.9.5 GlaxoSmithKline Plc Recent Development
11.10 Phylogica Limited
11.10.1 Phylogica Limited Company Detail
11.10.2 Phylogica Limited Business Overview
11.10.3 Phylogica Limited Acute Respiratory Distress Syndrome Therapeutics Introduction
11.10.4 Phylogica Limited Revenue in Acute Respiratory Distress Syndrome Therapeutics Business (2019-2024)
11.10.5 Phylogica Limited Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
FEATURED COMPANIES
Therabron Therapeutics Inc
Serendex Pharmaceuticals A/S
Silence Therapeutics Plc
Histocell S.L.
Altor BioScience Corporation
Athersys
Faron Pharmaceuticals Oy
FirstString Research Inc
GlaxoSmithKline PLC
Phylogica Ltd
List of Tables
    Table 1. Global Acute Respiratory Distress Syndrome Therapeutics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
    Table 2. Key Players of Methylprednisolone
    Table 3. Key Players of Hydrocortisone
    Table 4. Key Players of Calf Pulmonary Surfactant for Injection
    Table 5. Key Players of Others
    Table 6. Global Acute Respiratory Distress Syndrome Therapeutics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
    Table 7. Global Acute Respiratory Distress Syndrome Therapeutics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 8. Global Acute Respiratory Distress Syndrome Therapeutics Market Size by Region (2019-2024) & (US$ Million)
    Table 9. Global Acute Respiratory Distress Syndrome Therapeutics Market Share by Region (2019-2024)
    Table 10. Global Acute Respiratory Distress Syndrome Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 11. Global Acute Respiratory Distress Syndrome Therapeutics Market Share by Region (2025-2030)
    Table 12. Acute Respiratory Distress Syndrome Therapeutics Market Trends
    Table 13. Acute Respiratory Distress Syndrome Therapeutics Market Drivers
    Table 14. Acute Respiratory Distress Syndrome Therapeutics Market Challenges
    Table 15. Acute Respiratory Distress Syndrome Therapeutics Market Restraints
    Table 16. Global Acute Respiratory Distress Syndrome Therapeutics Revenue by Players (2019-2024) & (US$ Million)
    Table 17. Global Acute Respiratory Distress Syndrome Therapeutics Market Share by Players (2019-2024)
    Table 18. Global Top Acute Respiratory Distress Syndrome Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acute Respiratory Distress Syndrome Therapeutics as of 2023)
    Table 19. Ranking of Global Top Acute Respiratory Distress Syndrome Therapeutics Companies by Revenue (US$ Million) in 2023
    Table 20. Global 5 Largest Players Market Share by Acute Respiratory Distress Syndrome Therapeutics Revenue (CR5 and HHI) & (2019-2024)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Acute Respiratory Distress Syndrome Therapeutics Product Solution and Service
    Table 23. Date of Enter into Acute Respiratory Distress Syndrome Therapeutics Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Acute Respiratory Distress Syndrome Therapeutics Market Size by Type (2019-2024) & (US$ Million)
    Table 26. Global Acute Respiratory Distress Syndrome Therapeutics Revenue Market Share by Type (2019-2024)
    Table 27. Global Acute Respiratory Distress Syndrome Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 28. Global Acute Respiratory Distress Syndrome Therapeutics Revenue Market Share by Type (2025-2030)
    Table 29. Global Acute Respiratory Distress Syndrome Therapeutics Market Size by Application (2019-2024) & (US$ Million)
    Table 30. Global Acute Respiratory Distress Syndrome Therapeutics Revenue Market Share by Application (2019-2024)
    Table 31. Global Acute Respiratory Distress Syndrome Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 32. Global Acute Respiratory Distress Syndrome Therapeutics Revenue Market Share by Application (2025-2030)
    Table 33. North America Acute Respiratory Distress Syndrome Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 34. North America Acute Respiratory Distress Syndrome Therapeutics Market Size by Country (2019-2024) & (US$ Million)
    Table 35. North America Acute Respiratory Distress Syndrome Therapeutics Market Size by Country (2025-2030) & (US$ Million)
    Table 36. Europe Acute Respiratory Distress Syndrome Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 37. Europe Acute Respiratory Distress Syndrome Therapeutics Market Size by Country (2019-2024) & (US$ Million)
    Table 38. Europe Acute Respiratory Distress Syndrome Therapeutics Market Size by Country (2025-2030) & (US$ Million)
    Table 39. Asia-Pacific Acute Respiratory Distress Syndrome Therapeutics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 40. Asia-Pacific Acute Respiratory Distress Syndrome Therapeutics Market Size by Region (2019-2024) & (US$ Million)
    Table 41. Asia-Pacific Acute Respiratory Distress Syndrome Therapeutics Market Size by Region (2025-2030) & (US$ Million)
    Table 42. Latin America Acute Respiratory Distress Syndrome Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 43. Latin America Acute Respiratory Distress Syndrome Therapeutics Market Size by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Acute Respiratory Distress Syndrome Therapeutics Market Size by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Acute Respiratory Distress Syndrome Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 46. Middle East & Africa Acute Respiratory Distress Syndrome Therapeutics Market Size by Country (2019-2024) & (US$ Million)
    Table 47. Middle East & Africa Acute Respiratory Distress Syndrome Therapeutics Market Size by Country (2025-2030) & (US$ Million)
    Table 48. Therabron Therapeutics, Inc. Company Detail
    Table 49. Therabron Therapeutics, Inc. Business Overview
    Table 50. Therabron Therapeutics, Inc. Acute Respiratory Distress Syndrome Therapeutics Product
    Table 51. Therabron Therapeutics, Inc. Revenue in Acute Respiratory Distress Syndrome Therapeutics Business (2019-2024) & (US$ Million)
    Table 52. Therabron Therapeutics, Inc. Recent Development
    Table 53. Serendex Pharmaceuticals A/S Company Detail
    Table 54. Serendex Pharmaceuticals A/S Business Overview
    Table 55. Serendex Pharmaceuticals A/S Acute Respiratory Distress Syndrome Therapeutics Product
    Table 56. Serendex Pharmaceuticals A/S Revenue in Acute Respiratory Distress Syndrome Therapeutics Business (2019-2024) & (US$ Million)
    Table 57. Serendex Pharmaceuticals A/S Recent Development
    Table 58. Silence Therapeutics Plc Company Detail
    Table 59. Silence Therapeutics Plc Business Overview
    Table 60. Silence Therapeutics Plc Acute Respiratory Distress Syndrome Therapeutics Product
    Table 61. Silence Therapeutics Plc Revenue in Acute Respiratory Distress Syndrome Therapeutics Business (2019-2024) & (US$ Million)
    Table 62. Silence Therapeutics Plc Recent Development
    Table 63. Histocell S.L. Company Detail
    Table 64. Histocell S.L. Business Overview
    Table 65. Histocell S.L. Acute Respiratory Distress Syndrome Therapeutics Product
    Table 66. Histocell S.L. Revenue in Acute Respiratory Distress Syndrome Therapeutics Business (2019-2024) & (US$ Million)
    Table 67. Histocell S.L. Recent Development
    Table 68. Altor BioScience Corporation Company Detail
    Table 69. Altor BioScience Corporation Business Overview
    Table 70. Altor BioScience Corporation Acute Respiratory Distress Syndrome Therapeutics Product
    Table 71. Altor BioScience Corporation Revenue in Acute Respiratory Distress Syndrome Therapeutics Business (2019-2024) & (US$ Million)
    Table 72. Altor BioScience Corporation Recent Development
    Table 73. Athersys, Inc. Company Detail
    Table 74. Athersys, Inc. Business Overview
    Table 75. Athersys, Inc. Acute Respiratory Distress Syndrome Therapeutics Product
    Table 76. Athersys, Inc. Revenue in Acute Respiratory Distress Syndrome Therapeutics Business (2019-2024) & (US$ Million)
    Table 77. Athersys, Inc. Recent Development
    Table 78. Faron Pharmaceuticals Oy Company Detail
    Table 79. Faron Pharmaceuticals Oy Business Overview
    Table 80. Faron Pharmaceuticals Oy Acute Respiratory Distress Syndrome Therapeutics Product
    Table 81. Faron Pharmaceuticals Oy Revenue in Acute Respiratory Distress Syndrome Therapeutics Business (2019-2024) & (US$ Million)
    Table 82. Faron Pharmaceuticals Oy Recent Development
    Table 83. FirstString Research, Inc. Company Detail
    Table 84. FirstString Research, Inc. Business Overview
    Table 85. FirstString Research, Inc. Acute Respiratory Distress Syndrome Therapeutics Product
    Table 86. FirstString Research, Inc. Revenue in Acute Respiratory Distress Syndrome Therapeutics Business (2019-2024) & (US$ Million)
    Table 87. FirstString Research, Inc. Recent Development
    Table 88. GlaxoSmithKline Plc Company Detail
    Table 89. GlaxoSmithKline Plc Business Overview
    Table 90. GlaxoSmithKline Plc Acute Respiratory Distress Syndrome Therapeutics Product
    Table 91. GlaxoSmithKline Plc Revenue in Acute Respiratory Distress Syndrome Therapeutics Business (2019-2024) & (US$ Million)
    Table 92. GlaxoSmithKline Plc Recent Development
    Table 93. Phylogica Limited Company Detail
    Table 94. Phylogica Limited Business Overview
    Table 95. Phylogica Limited Acute Respiratory Distress Syndrome Therapeutics Product
    Table 96. Phylogica Limited Revenue in Acute Respiratory Distress Syndrome Therapeutics Business (2019-2024) & (US$ Million)
    Table 97. Phylogica Limited Recent Development
    Table 98. Research Programs/Design for This Report
    Table 99. Key Data Information from Secondary Sources
    Table 100. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Acute Respiratory Distress Syndrome Therapeutics Market Size Comparison by Type (2024-2030) & (US$ Million)
    Figure 2. Global Acute Respiratory Distress Syndrome Therapeutics Market Share by Type: 2023 VS 2030
    Figure 3. Methylprednisolone Features
    Figure 4. Hydrocortisone Features
    Figure 5. Calf Pulmonary Surfactant for Injection Features
    Figure 6. Others Features
    Figure 7. Global Acute Respiratory Distress Syndrome Therapeutics Market Size Comparison by Application (2024-2030) & (US$ Million)
    Figure 8. Global Acute Respiratory Distress Syndrome Therapeutics Market Share by Application: 2023 VS 2030
    Figure 9. In-Patient Case Studies
    Figure 10. Out-Patient Case Studies
    Figure 11. Acute Respiratory Distress Syndrome Therapeutics Report Years Considered
    Figure 12. Global Acute Respiratory Distress Syndrome Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 13. Global Acute Respiratory Distress Syndrome Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 14. Global Acute Respiratory Distress Syndrome Therapeutics Market Share by Region: 2023 VS 2030
    Figure 15. Global Acute Respiratory Distress Syndrome Therapeutics Market Share by Players in 2023
    Figure 16. Global Top Acute Respiratory Distress Syndrome Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acute Respiratory Distress Syndrome Therapeutics as of 2023)
    Figure 17. The Top 10 and 5 Players Market Share by Acute Respiratory Distress Syndrome Therapeutics Revenue in 2023
    Figure 18. North America Acute Respiratory Distress Syndrome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 19. North America Acute Respiratory Distress Syndrome Therapeutics Market Share by Country (2019-2030)
    Figure 20. United States Acute Respiratory Distress Syndrome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 21. Canada Acute Respiratory Distress Syndrome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 22. Europe Acute Respiratory Distress Syndrome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. Europe Acute Respiratory Distress Syndrome Therapeutics Market Share by Country (2019-2030)
    Figure 24. Germany Acute Respiratory Distress Syndrome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. France Acute Respiratory Distress Syndrome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. U.K. Acute Respiratory Distress Syndrome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. Italy Acute Respiratory Distress Syndrome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. Russia Acute Respiratory Distress Syndrome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. Nordic Countries Acute Respiratory Distress Syndrome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. Asia-Pacific Acute Respiratory Distress Syndrome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Asia-Pacific Acute Respiratory Distress Syndrome Therapeutics Market Share by Region (2019-2030)
    Figure 32. China Acute Respiratory Distress Syndrome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Japan Acute Respiratory Distress Syndrome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. South Korea Acute Respiratory Distress Syndrome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. Southeast Asia Acute Respiratory Distress Syndrome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. India Acute Respiratory Distress Syndrome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. Australia Acute Respiratory Distress Syndrome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 38. Latin America Acute Respiratory Distress Syndrome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 39. Latin America Acute Respiratory Distress Syndrome Therapeutics Market Share by Country (2019-2030)
    Figure 40. Mexico Acute Respiratory Distress Syndrome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 41. Brazil Acute Respiratory Distress Syndrome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. Middle East & Africa Acute Respiratory Distress Syndrome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. Middle East & Africa Acute Respiratory Distress Syndrome Therapeutics Market Share by Country (2019-2030)
    Figure 44. Turkey Acute Respiratory Distress Syndrome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Saudi Arabia Acute Respiratory Distress Syndrome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Therabron Therapeutics, Inc. Revenue Growth Rate in Acute Respiratory Distress Syndrome Therapeutics Business (2019-2024)
    Figure 47. Serendex Pharmaceuticals A/S Revenue Growth Rate in Acute Respiratory Distress Syndrome Therapeutics Business (2019-2024)
    Figure 48. Silence Therapeutics Plc Revenue Growth Rate in Acute Respiratory Distress Syndrome Therapeutics Business (2019-2024)
    Figure 49. Histocell S.L. Revenue Growth Rate in Acute Respiratory Distress Syndrome Therapeutics Business (2019-2024)
    Figure 50. Altor BioScience Corporation Revenue Growth Rate in Acute Respiratory Distress Syndrome Therapeutics Business (2019-2024)
    Figure 51. Athersys, Inc. Revenue Growth Rate in Acute Respiratory Distress Syndrome Therapeutics Business (2019-2024)
    Figure 52. Faron Pharmaceuticals Oy Revenue Growth Rate in Acute Respiratory Distress Syndrome Therapeutics Business (2019-2024)
    Figure 53. FirstString Research, Inc. Revenue Growth Rate in Acute Respiratory Distress Syndrome Therapeutics Business (2019-2024)
    Figure 54. GlaxoSmithKline Plc Revenue Growth Rate in Acute Respiratory Distress Syndrome Therapeutics Business (2019-2024)
    Figure 55. Phylogica Limited Revenue Growth Rate in Acute Respiratory Distress Syndrome Therapeutics Business (2019-2024)
    Figure 56. Bottom-up and Top-down Approaches for This Report
    Figure 57. Data Triangulation
    Figure 58. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

Global Respiratory Distress Syndrome Market Insights Forecast to 2030
Neonatal Respiratory Distress Syndrome Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Acute Respiratory Distress Syndrome Device Market Research Report 2024
Preterm Birth Prevention and Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Lung Surfactants Market Research Report 2024
Global Infant Resuscitation Therapy System Market Research Report 2025
Preterm Birth Prevention and Management Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Mechanical Neonatal Ventilators Market Insights Forecast to 2030
Bronchopulmonary Dysplasia Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Medical Neonatal Ventilators Market Insights Forecast to 2030
Global Neonatal Intensive Care Ventilators Market Insights Forecast to 2030
Global Intensive Care Neonatal Ventilators Market Insights Forecast to 2030
Global Acute Respiratory Distress Syndrome Ventilation Treatment Device Market Research Report 2024
Pressure Mode Neonatal Ventilators Market
Global Human Respiratory Syncytial Virus RSV Treatment Market Research Report 2024
Global Acute Respiratory Distress Syndrome Treatment Device Market Research Report 2024
Global Neonatal Noninvasive Ventilator Market Insights Forecast to 2030
Breathing Disorders Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Neonatal Preterm Infant Care Market Insights Forecast to 2030
Global Neonatal High Frequency Ventilator Market Research Report 2024

RELATED REPORTS

Global Insulin Coolers Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19Z7671
Thu Sep 18 00:00:00 UTC 2025

Add to Cart

Global Ossicular Prostheses Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10V14317
Thu Sep 18 00:00:00 UTC 2025

Add to Cart

Global Defibrillator Accessories Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10O5919
Thu Sep 18 00:00:00 UTC 2025

Add to Cart

Global Septicemia Diagnostic Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-4I19963
Thu Sep 18 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions